Structure Therapeutics Inc. (GPCR) stock
GPCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$20.00+0.16 (+0.81%)
Close on Nov 13, 2026Market cap $1.43BP/E –Yield –
Structure Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Structure Therapeutics's enterprise value was $149.32M on Nov 11, 2026, against $1.37B a year earlier. Over the last 4 years it ranged from -$7.36M to $4.57B, with a median of $1.13B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $149.32M | -95.6% |
| 2025 | Dec 31, 2025 | $3.42B | +436.7% |
| 2024 | Dec 31, 2024 | $637.43M | -25.2% |
| 2023 | Dec 29, 2023 | $852.37M | – |
See a number that looks wrong?